vs
科迪华（CTVA）与Quanex Building Products CORP（NX）财务数据对比。点击上方公司名可切换其他公司
科迪华的季度营收约是Quanex Building Products CORP的7.9倍（$3.9B vs $495.3M）。科迪华净利率更高（-14.1% vs -55.7%，领先41.6%）。Quanex Building Products CORP同比增速更快（76.7% vs -1.7%）。科迪华自由现金流更多（$4.2B vs $46.2M）。过去两年Quanex Building Products CORP的营收复合增速更高（29.5% vs -6.7%）
科迪华是一家美国农业科技企业，主营种子与作物保护产品，涵盖除草剂、杀虫剂、杀菌剂及生物制剂，业务覆盖全球110个国家，总部位于印第安纳州印第安纳波利斯，旗下大部分种子产品以先锋良种国际品牌销售。
Quanex Building Products是一家工程建筑组件及材料制造商，核心产品包括中空玻璃间隔条、门窗系统、橱柜及家具部件，服务北美、欧洲的住宅及商业建筑市场，主打节能可持续的建筑解决方案。
CTVA vs NX — 直观对比
营收规模更大
CTVA
是对方的7.9倍
$495.3M
营收增速更快
NX
高出78.4%
-1.7%
净利率更高
CTVA
高出41.6%
-55.7%
自由现金流更多
CTVA
多$4.1B
$46.2M
两年增速更快
NX
近两年复合增速
-6.7%
损益表 — Q4 2025 vs Q3 2025
| 指标 | | |
|---|---|---|
| 营收 | $3.9B | $495.3M |
| 净利润 | $-552.0M | $-276.0M |
| 毛利率 | 42.4% | 27.9% |
| 营业利润率 | -13.6% | -54.7% |
| 净利率 | -14.1% | -55.7% |
| 营收同比 | -1.7% | 76.7% |
| 净利润同比 | -1246.3% | -1188.8% |
| 每股收益（稀释后） | $-0.80 | $-6.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTVANX
| Q4 25 | $3.9B | — | ||
| Q3 25 | $2.6B | $495.3M | ||
| Q2 25 | $6.5B | $452.5M | ||
| Q1 25 | $4.4B | $400.0M | ||
| Q4 24 | $4.0B | $492.2M | ||
| Q3 24 | $2.3B | $280.3M | ||
| Q2 24 | $6.1B | $266.2M | ||
| Q1 24 | $4.5B | $239.2M |
净利润CTVANX
| Q4 25 | $-552.0M | — | ||
| Q3 25 | $-320.0M | $-276.0M | ||
| Q2 25 | $1.3B | $20.5M | ||
| Q1 25 | $652.0M | $-14.9M | ||
| Q4 24 | $-41.0M | $-13.9M | ||
| Q3 24 | $-524.0M | $25.4M | ||
| Q2 24 | $1.1B | $15.4M | ||
| Q1 24 | $419.0M | $6.2M |
毛利率CTVANX
| Q4 25 | 42.4% | — | ||
| Q3 25 | 37.2% | 27.9% | ||
| Q2 25 | 54.6% | 29.0% | ||
| Q1 25 | 47.0% | 23.1% | ||
| Q4 24 | 37.3% | — | ||
| Q3 24 | 32.7% | 25.3% | ||
| Q2 24 | 52.3% | 24.9% | ||
| Q1 24 | 43.2% | 21.5% |
营业利润率CTVANX
| Q4 25 | -13.6% | — | ||
| Q3 25 | -14.1% | -54.7% | ||
| Q2 25 | 27.9% | 9.0% | ||
| Q1 25 | 17.7% | -1.7% | ||
| Q4 24 | 2.2% | 0.6% | ||
| Q3 24 | -27.2% | 8.4% | ||
| Q2 24 | 21.9% | 7.8% | ||
| Q1 24 | 10.7% | 3.3% |
净利率CTVANX
| Q4 25 | -14.1% | — | ||
| Q3 25 | -12.2% | -55.7% | ||
| Q2 25 | 20.4% | 4.5% | ||
| Q1 25 | 14.8% | -3.7% | ||
| Q4 24 | -1.0% | -2.8% | ||
| Q3 24 | -22.5% | 9.0% | ||
| Q2 24 | 17.2% | 5.8% | ||
| Q1 24 | 9.3% | 2.6% |
每股收益（稀释后）CTVANX
| Q4 25 | $-0.80 | — | ||
| Q3 25 | $-0.47 | $-6.04 | ||
| Q2 25 | $1.92 | $0.44 | ||
| Q1 25 | $0.95 | $-0.32 | ||
| Q4 24 | $-0.05 | $-0.52 | ||
| Q3 24 | $-0.76 | $0.77 | ||
| Q2 24 | $1.51 | $0.46 | ||
| Q1 24 | $0.60 | $0.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | $66.3M |
| 总债务越低越好 | $1.7B | $695.6M |
| 股东权益账面价值 | $24.1B | $717.4M |
| 总资产 | $42.8B | $2.0B |
| 负债/权益比越低杠杆越低 | 0.07× | 0.97× |
8季度趋势，按日历期对齐
现金及短期投资CTVANX
| Q4 25 | $4.5B | — | ||
| Q3 25 | $2.6B | $66.3M | ||
| Q2 25 | $2.1B | $62.6M | ||
| Q1 25 | $2.0B | $50.0M | ||
| Q4 24 | $3.2B | $97.7M | ||
| Q3 24 | $2.5B | $94.0M | ||
| Q2 24 | $2.0B | $56.1M | ||
| Q1 24 | $1.7B | $44.4M |
总债务CTVANX
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.7B | $695.6M | ||
| Q2 25 | $1.7B | $746.4M | ||
| Q1 25 | $1.8B | $725.2M | ||
| Q4 24 | $2.0B | $737.2M | ||
| Q3 24 | $2.0B | $51.4M | ||
| Q2 24 | $2.5B | $51.5M | ||
| Q1 24 | $2.5B | $61.6M |
股东权益CTVANX
| Q4 25 | $24.1B | — | ||
| Q3 25 | $25.2B | $717.4M | ||
| Q2 25 | $25.9B | $1.0B | ||
| Q1 25 | $24.3B | $972.1M | ||
| Q4 24 | $23.8B | $1.0B | ||
| Q3 24 | $24.7B | $594.1M | ||
| Q2 24 | $25.2B | $566.1M | ||
| Q1 24 | $24.8B | $555.0M |
总资产CTVANX
| Q4 25 | $42.8B | — | ||
| Q3 25 | $42.2B | $2.0B | ||
| Q2 25 | $41.8B | $2.3B | ||
| Q1 25 | $42.1B | $2.2B | ||
| Q4 24 | $40.8B | $2.3B | ||
| Q3 24 | $41.9B | $872.5M | ||
| Q2 24 | $41.5B | $837.2M | ||
| Q1 24 | $43.6B | $813.4M |
负债/权益比CTVANX
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.07× | 0.97× | ||
| Q2 25 | 0.07× | 0.75× | ||
| Q1 25 | 0.07× | 0.75× | ||
| Q4 24 | 0.08× | 0.73× | ||
| Q3 24 | 0.08× | 0.09× | ||
| Q2 24 | 0.10× | 0.09× | ||
| Q1 24 | 0.10× | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.4B | $60.7M |
| 自由现金流经营现金流 - 资本支出 | $4.2B | $46.2M |
| 自由现金流率自由现金流/营收 | 106.2% | 9.3% |
| 资本支出强度资本支出/营收 | 5.7% | 2.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $2.8B | $27.5M |
8季度趋势，按日历期对齐
经营现金流CTVANX
| Q4 25 | $4.4B | — | ||
| Q3 25 | $193.0M | $60.7M | ||
| Q2 25 | $947.0M | $28.5M | ||
| Q1 25 | $-2.1B | $-12.5M | ||
| Q4 24 | $4.2B | $5.5M | ||
| Q3 24 | $130.0M | $46.4M | ||
| Q2 24 | $451.0M | $33.1M | ||
| Q1 24 | $-2.6B | $3.9M |
自由现金流CTVANX
| Q4 25 | $4.2B | — | ||
| Q3 25 | $36.0M | $46.2M | ||
| Q2 25 | $829.0M | $13.6M | ||
| Q1 25 | $-2.2B | $-24.1M | ||
| Q4 24 | $4.0B | $-8.2M | ||
| Q3 24 | $-24.0M | $40.1M | ||
| Q2 24 | $337.0M | $25.5M | ||
| Q1 24 | $-2.8B | $-5.7M |
自由现金流率CTVANX
| Q4 25 | 106.2% | — | ||
| Q3 25 | 1.4% | 9.3% | ||
| Q2 25 | 12.8% | 3.0% | ||
| Q1 25 | -49.9% | -6.0% | ||
| Q4 24 | 100.4% | -1.7% | ||
| Q3 24 | -1.0% | 14.3% | ||
| Q2 24 | 5.5% | 9.6% | ||
| Q1 24 | -61.4% | -2.4% |
资本支出强度CTVANX
| Q4 25 | 5.7% | — | ||
| Q3 25 | 6.0% | 2.9% | ||
| Q2 25 | 1.8% | 3.3% | ||
| Q1 25 | 2.1% | 2.9% | ||
| Q4 24 | 4.6% | 2.8% | ||
| Q3 24 | 6.6% | 2.2% | ||
| Q2 24 | 1.9% | 2.9% | ||
| Q1 24 | 3.3% | 4.0% |
现金转化率CTVANX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.72× | 1.39× | ||
| Q1 25 | -3.23× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.83× | ||
| Q2 24 | 0.43× | 2.15× | ||
| Q1 24 | -6.23× | 0.62× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTVA
| Corn | $1.4B | 35% |
| Herbicides | $1.1B | 27% |
| Insecticides | $488.0M | 12% |
| Fungicides | $272.0M | 7% |
| Biologicals | $191.0M | 5% |
| Soybean | $164.0M | 4% |
| Other | $160.0M | 4% |
| Otheroilseeds | $94.0M | 2% |
NX
| Window And Door Hardware | $150.3M | 30% |
| Screens | $76.8M | 16% |
| Window Profiles | $68.2M | 14% |
| Spacers | $54.7M | 11% |
| Wood Solutions | $53.4M | 11% |
| Seals And Gaskets | $29.9M | 6% |
| Access Solutions | $27.4M | 6% |
| Mixing Solution | $21.5M | 4% |
| Solar | $5.3M | 1% |
| Product Type Other | $3.3M | 1% |
